On the financial front, Abbott reported revenue of $43.6 billion last year, up 1.3%, though EPS was down to $3.91 compared to $3.94 a year earlier.

Revenue through the first nine months of fiscal 2023 was down 3.4%, year over year, and net income was off by 37.8%, but recent catalysts have boosted the company's stock, which is up more than 15 ...

The funding supports development of an assay to detect and differentiate H5 influenza A from seasonal H1 and H3 subtypes, flu B, and COVID-19.

Jan 8 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab said on Monday it had agreed to buy Axonics Inc (AXNX.O), opens new tab for $3.7 billion, gaining access to devices ...

BEIJING/HONG KONG, Jan 29 (Reuters) - Chinese medical device company Shenzhen Mindray Bio-Medical Electronics (300760.SZ) said it planned a 6.65 billion yuan ($927 million) deal to gain control of ...